MCID: RBL001
MIFTS: 56

Rubella malady

Categories: Rare diseases, Infectious diseases, Skin diseases, Fetal diseases, Neuronal diseases

Aliases & Classifications for Rubella

About this section

Summaries for Rubella

About this section
MedlinePlus:38 Rubella is an infection caused by a virus. it is usually mild with fever and a rash. about half of the people who get rubella do not have symptoms. if you do get them, symptoms may include a rash that starts on the face and spreads to the body mild fever aching joints, especially in young women swollen glands rubella is most dangerous for a pregnant woman's baby. it can cause miscarriage or birth defects. rubella spreads when an infected person coughs or sneezes. people without symptoms can still spread it. there is no treatment, but the measles-mumps-rubella (mmr) vaccine can prevent it. centers for disease control and prevention

MalaCards based summary: Rubella, also known as german measles, is related to myelitis and malignant histiocytosis, and has symptoms including rash on the face which spreads to the trunk, fever and lymphadenopathy. An important gene associated with Rubella is CD40LG (CD40 Ligand), and among its related pathways are Antigen Presentation- Folding, assembly and peptide loading of class I MHC and Staphylococcus aureus infection. Affiliated tissues include skin, skin and eye, and related mouse phenotype Increased shRNA abundance.

CDC:2 Rubella is a contagious disease caused by a virus. Most people who get rubella usually have a mild illness, with symptoms that can include a low-grade fever, sore throat, and a rash that starts on the face and spreads to the rest of the body. Rubella can cause a miscarriage or serious birth defects in an developing baby if a woman is infected while she is pregnant. The best protection against rubella is MMR (measles-mumps-rubella) vaccine.

Disease Ontology:11 A viral infectious disease that results in infection located in skin, has material basis in Rubella virus, which is transmitted by droplet spread of oronasal secretions from the infected person through coughing and sneezing, and transmitted by congenital method. The infection has symptom rash on the face which spreads to the trunk and limbs, has symptom fever, has symptom lymphadenopathy, has symptom joint pains, has symptom headache, and has symptom conjunctivitis.

Wikipedia:71 Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus.... more...

Related Diseases for Rubella

About this section

Diseases in the Rubella family:

Congenital Rubella

Diseases related to Rubella via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 283)
idRelated DiseaseScoreTop Affiliating Genes
1myelitis30.1CD40LG, MOG, TNF
2malignant histiocytosis29.3CD40LG, IL4, TNF
3asthma28.5CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL4, TNF
4congenital rubella12.5
5rubella panencephalitis11.9
6measles11.4
7mumps11.3
8cytomegalic inclusion disease11.1
9infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations10.8
10togaviridae disease10.8
11fruit allergy10.5HLA-DQB1, HLA-DRB1
12wolffian duct adenocarcinoma10.5HLA-DQB1, HLA-DRB1
13quinquaud's decalvans folliculitis10.5HLA-DQB1, HLA-DRB1
14pediatric systemic lupus erythematosus10.5HLA-DQB1, HLA-DRB1
15spondylarthropathy10.5HLA-DQB1, HLA-DRB1
16anthracosilicosis10.5HLA-DPB1, HLA-DRB1
17acute diffuse nephritis10.5CD40LG, HLA-B
18night blindness10.4CD40LG, TNF
19malignant cardiac germ cell tumor10.4HLA-A, HLA-DQB1
20rheumatic myocarditis10.4HLA-DQB1, HLA-DRB1
21brucella abortus brucellosis10.4CD40LG, TNF
22lens-induced iridocyclitis10.4CD40LG, HLA-DPB1
23weber syndrome10.4HLA-DRB1, TNF
24multifocal choroiditis10.4HLA-DRB1, MOG
25branch retinal artery occlusion10.4HLA-A, HLA-B
26newborn respiratory distress syndrome10.4HLA-DPB1, HLA-DRB1, MOG
27gonococcal iridocyclitis10.4HLA-A, HLA-B
28rhizomelic pseudopolyarthritis10.3HLA-DRB1, TNF
29nebulin-related early-onset distal myopathy10.3HLA-DQB1, HLA-DRB1
30aniseikonia10.3CD40LG, IL4
31vitreoretinochoroidopathy dominant10.3HLA-B, HLA-DQB1, HLA-DRB1
32abdominal chemodectomas with cutaneous angiolipomas10.3HLA-DRB1, TNF
336q terminal deletion syndrome10.3IL4, TNF
34granular cell tumor10.3CD40LG, IL4
35x-linked congenital generalized hypertrichosis10.3HLA-B, HLA-DQB1, HLA-DRB1
36myositis fibrosa10.3CD40LG, IL4
37bullous retinoschisis10.3HLA-DRB1, MOG, TNF
38krieble bixler syndrome10.3HLA-DQB1, HLA-DRB1, TNF
39fibrous histiocytoma10.3CD40LG, HLA-DRB1, TNF
40angiomyolipoma10.3CD40LG, MOG, TNF
41idiopathic central precocious puberty10.3HLA-DQB1, HLA-DRB1, TNF
42bile duct signet ring cell carcinoma10.3CD40LG, HLA-DRB1, TNF
43renovascular hypertension10.3CD40LG, HLA-DRB1, TNF
44basidiobolomycosis10.3IL4, TNF
45chronic apical periodontitis10.3CD40LG, HLA-DRB1, TNF
46paralytic lagophthalmos10.3IL4, TNF
47retroperitoneal fibrosis10.3CD40LG, HLA-DRB1, TNF
48caplan's syndrome10.3CD40LG, HLA-A, HLA-DPB1
49reproductive system disease10.3CD40LG, HLA-DRB1, TNF
50chronic intestinal vascular insufficiency10.2CD40LG, MOG, TNF

Graphical network of the top 20 diseases related to Rubella:



Diseases related to rubella

Symptoms & Phenotypes for Rubella

About this section

Symptoms:

 11 (show all 6)
  • rash on the face which spreads to the trunk
  • fever
  • lymphadenopathy
  • joint pains
  • headache
  • conjunctivitis

UMLS symptoms related to Rubella:


exanthema, pruritus, rubella arthralgia

GenomeRNAi Phenotypes related to Rubella according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00327-A8.6HLA-B, HLA-DPB1, HLA-DQB1, IL4

Drugs & Therapeutics for Rubella

About this section

Drugs for Rubella (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1VaccinesPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 16428
2AntibodiesPhase 4, Phase 2, Phase 16045
3ImmunoglobulinsPhase 4, Phase 2, Phase 16045
4Pharmaceutical SolutionsPhase 4, Phase 3, Phase 27793
5Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2454
6Liver ExtractsPhase 43868
7
Tetracyclineapproved, vet_approvedPhase 39960-54-85353990
Synonyms:
(-)-Tetracycline
(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
6-Methyl-1,11-dioxy-2-naphthacenecarboxamide
60-54-8
64-75-5 (mono-hydrochloride)
6591-49-7
87128_FLUKA
87128_SIGMA
AC-13151
AC1L1KAT
AC1NQXT7
AC1NRDAM
AC1NS4RQ
AC1NSDX8
AC1NTUT2
AC1NUZHL
AC1O52HS
Abramycin
Abricycline
Achromycin
Achromycin (naphthacene derivative)
Achromycin V
Achromycin, naphthacene derivative
Agromicina
Ambramicina
Ambramycin
Amycin
Anhydrotetracycline
BIDD:GT0653
BPBio1_000242
BSPBio_000220
BSPBio_001950
Bio-tetra
Biocycline
Bristaciclin
Bristaciclin .alpha.
Bristaciclina
Bristacycline
C06570
CHEBI:27902
CHEMBL1440
CID12309720
CID5280962
CID5289435
CID5353990
CID5359245
CID5388997
CID5412
CID5497101
CID6426717
Cefracycline
Cefracycline suspension
Centet (base)
Ciclibion
Copharlan
Criseociclina
Cyclomycin
Cyclopar
Cytome
D00201
DB00759
Democracin
Deschlorobiomycin
DivK1c_000827
Dumocyclin
EINECS 200-481-9
Enterocycline
HMS2090B04
HSDB 3188
Hostacyclin
IDI1_000827
KBio1_000827
KBio2_001514
KBio2_004082
KBio2_006650
KBio3_001450
KBioGR_000783
KBioSS_001514
LS-187078
LS-93869
Lemtrex (base)
Lexacycline
Limecycline
Liquamycin
Liquamycin (Veterinary)
 
Liquamycin, veterinary
MLS000069728
Medocycline
Mericycline
Micycline
MolPort-001-794-633
MolPort-003-983-460
MolPort-005-934-198
NCGC00161665-01
NINDS_000827
NSC 108579
NSC108579
Neocycline
Omegamycin
Orlycycline
Panmycin
Piracaps (base)
Polycycline
Polycycline (VAN)
Polycycline (antibiotic)
Polycycline, antibiotic
Polyotic
Prestwick0_000140
Prestwick1_000140
Prestwick2_000140
Prestwick3_000140
Purocyclina
Resteclin
Robitet
Roviciclina
SK-Tetracycline
SMR000058220
SPBio_001457
SPBio_002159
STOCK1N-42738
Sanclomycine
Solvocin
Spectrum2_001329
Spectrum3_000565
Spectrum4_000352
Spectrum5_001112
Spectrum_001034
Sumycin
Sumycin (TN)
Sumycin syrup
T-125
T3258_SIGMA
Tetra-Co
Tetrabon
Tetrachel
Tetraciclina
Tetraciclina [INN-Spanish]
Tetracycl
Tetracyclin
Tetracycline & VRC3375
Tetracycline (JAN/USP/INN)
Tetracycline (internal use)
Tetracycline Free Base
Tetracycline HCl
Tetracycline I
Tetracycline II
Tetracycline Monohydrochloride
Tetracycline [USAN:INN:BAN:JAN]
Tetracyclinum
Tetracyclinum [INN-Latin]
Tetracyn
Tetradecin
Tetrafil
Tetraverine
Tetrazyklin
Topicycline
Tsiklomistsin
Tsiklomitsin
Tétracycline
UNII-F8VB5M810T
UPCMLD-DP127
UPCMLD-DP127:001
UPCMLD-DP127:002
Veracin
Vetacyclinum
Vetquamycin-324 (free base)
WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ
component of Tetrastatin
methyl-1,11-dioxo-2-naphthacenecarboxamide
nchembio.273-comp1
nchembio.289-comp1
tetracycline
8
Aluminum hydroxideapprovedPhase 3, Phase 220121645-51-2
Synonyms:
Al(OH)3
Aluminium hydroxide
Aluminium hydroxide gel, dried
 
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
9
Vitamin Aapproved, nutraceutical, vet_approvedPhase 346811103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
10
LactitolPhase 3, Phase 2332585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
11PENTAPhase 3, Phase 2109
12Anti-Infective AgentsPhase 321402
13Anti-Bacterial AgentsPhase 310884
14Retinol palmitatePhase 3468
15VitaminsPhase 35095
16Trace ElementsPhase 35802
17MicronutrientsPhase 35802
18AntioxidantsPhase 32928
19Protective AgentsPhase 37190
20retinolNutraceuticalPhase 3468
21
AltretamineapprovedPhase 259645-05-62123
Synonyms:
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-S-triazine
2,4,6-Tris(dimethylamino)-s-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
549835_ALDRICH
645-05-6
A 8723
A0567/0026158
A8723_SIGMA
AB00052308
AC-12006
AC1L1CYX
AI3-50852
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
Altretamine (USP/INN)
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretamine [USAN:INN:BAN]
Altretaminum
Altretaminum [INN-Latin]
Altrétamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
Bellon Brand of Altretamine
C9H18N6
CAS-654-05-6
CCRIS 5492
CHEBI:24564
CHEMBL1455
CID2123
CPD000058181
ChemDiv2_005185
Chiesi Brand of Altretamine
D006585
D02841
DB00488
DivK1c_000772
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
HEXAMETHYLMELAMINE
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS502G14
HSDB 7559
HTM
HXM
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
 
Hexamethylmelamine
Hexastat
Hexinawas
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
LS-1549
Lopac-A-8723
Lopac0_000083
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-06
NCGC00015100-11
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCI-C50259
NCI60_000871
NINDS_000772
NSC 13875
NSC-13875
NSC13875
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
S1278_Selleck
SAM002564241
SMR000058181
SPBio_000754
SPBio_003071
SPECTRUM1503065
ST086739
STK749184
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
Spectrum_001308
UNII-Q8BIH59O7H
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
Wassermann Brand of Altretamine
ZINC00000905
altretamine
no)-s-triazine
22AnticoagulantsPhase 22516
23Fibrinolytic AgentsPhase 22317
24Immunoglobulin GPhase 1265
25Immunoglobulin MPhase 19
26AutoantibodiesPhase 1126
27
Certolizumab pegolapproved122428863-50-7
Synonyms:
428863-50-7
CDP870
Certolizumab pegol
 
Certolizumab pegol (USAN/INN)
Certolizumab pegol (genetical recombination)
Certolizumab pegol (genetical recombination) (JAN)
D03441
cimzia
28
Infliximabapproved378170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
29
Methotrexateapproved15181959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
30
Azathioprineapproved165446-86-62265
Synonyms:
446-86-6
55774-33-9 (hydrochloride salt)
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine
6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]
6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine
6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
6-(Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(Methyl-p-nitro-5-imidazolyl)thiopurine
6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine
6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine
6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine
6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
A 4638
A2593_SIAL
A4638_SIAL
A4638_SIGMA
AB00443544
AB00443544-03
AC-4230
AC1L1DAL
AC1Q3Z1F
AI-981/34845012
AI3-50290
Azamun
Azamun [Czech]
Azanin
Azasan
Azasan (TN)
Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine
Azathioprin
Azathioprine (JP15/USP/INN)
Azathioprine Sodium
Azathioprine [USAN:INN:BAN:JAN]
Azathioprine sodium
Azathioprinum
Azathioprinum [INN-Latin]
Azathiopurine
Azatioprin
Azatioprina
Azatioprina [INN-Spanish]
Azothioprine
B. W. 57-322
BPBio1_000054
BRD-K32821942-001-05-6
BRD-K60324116-001-01-5
BSPBio_000048
BSPBio_001876
BW 57-322
BW 57322
BW-57-322
C06837
C9H7N7O2S
CAS-446-86-6
CBDivE_013132
CCRIS 62
CHEBI:2948
CHEMBL1542
CID2265
CPD000427366
Ccucol
ChemDiv1_002659
Cytostatics
D00238
DB00993
DivK1c_000586
EINECS 207-175-4
EU-0100027
FT-0083532
HMS1568C10
HMS1920E17
 
HMS2091K19
HMS501N08
HMS594I19
HSDB 7084
IDI1_000586
Immuran
Imuran
Imuran (TN)
Imuran (tn)
Imurek
Imurel
KBio1_000586
KBio2_000464
KBio2_002427
KBio2_003032
KBio2_004995
KBio2_005600
KBio2_007563
KBio3_001376
KBio3_002906
KBioGR_000646
KBioGR_002427
KBioSS_000464
KBioSS_002433
LS-123
Lopac-A-4638
Lopac0_000027
MLS001049307
Methylnitroimidazolylmercaptopurine
MolPort-000-745-914
MolPort-000-764-262
MolPort-003-665-485
Muran
NCGC00015060-01
NCGC00015060-02
NCGC00015060-04
NCGC00015060-12
NCGC00090836-01
NCGC00090836-02
NCGC00090836-03
NCGC00090836-04
NCGC00090836-05
NCGC00090836-06
NCGC00094593-01
NCGC00094593-02
NCGC00094593-03
NCI-C03474
NINDS_000586
NSC 39084
NSC-39084
NSC39084
Oprea1_375441
Oprea1_533384
Oprea1_633462
Prestwick0_000094
Prestwick1_000094
Prestwick2_000094
Prestwick3_000094
Prestwick_41
S1721_Selleck
SAM002589938
SDCCGMLS-0065415.P001
SMR000427366
SPBio_000255
SPBio_001987
SPECTRUM1500133
STK831906
STOCK1S-20293
STOCK1S-27186
Spectrum2_000068
Spectrum3_000308
Spectrum4_000243
Spectrum5_000848
Spectrum_000064
Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)
UNII-MRK240IY2L
WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW
ZINC04258316
[Methyl(nitroimidazolyl)mercaptopurine]
azathioprine
azatiopr in
cMAP_000046
31
Adalimumabapproved478331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
32Anti-HIV Agents3100
336-Mercaptopurine199
34Adjuvants, Immunologic2484
35AcidophilusNutraceutical518

Interventional clinical trials:

(show top 50)    (show all 124)
idNameStatusNCT IDPhase
1The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR VaccineUnknown statusNCT02153866Phase 4
2Coadministration of Measles-rubella and Rotavirus VaccinesCompletedNCT01700621Phase 4
3Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
4Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic ArthritisCompletedNCT00731965Phase 4
5Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose PresentationsCompletedNCT01777529Phase 4
6Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
7Immunogenicity of Co-administration of Measles and Japanese Encephalitis VaccinesCompletedNCT02643433Phase 4
8Measles, Mumps, and Rubella (MMR) Immunity in College StudentsCompletedNCT00962819Phase 4
9MMR Vaccination Among HIV-infected AdultsCompletedNCT02724852Phase 4
10Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.CompletedNCT00388440Phase 4
11Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
12IPV Clinical Trial - The GambiaCompletedNCT01847872Phase 4
13MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
14Safety Study of a Refrigerator-Stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
15Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old ChildrenCompletedNCT02253407Phase 4
16Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
17Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella VaccineRecruitingNCT02880865Phase 4
18Homeopathic Vaccine TrialRecruitingNCT02825368Phase 4
19Induction of Immunity Against Measles in Pediatric Liver Transplant RecipientsRecruitingNCT01770119Phase 4
20Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMRActive, not recruitingNCT02325310Phase 4
21Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
22Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy InfantsUnknown statusNCT01763268Phase 2, Phase 3
23Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
24Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
25Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and OlderCompletedNCT02058563Phase 3
26Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3
27Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedNCT01536405Phase 3
28Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
29Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.CompletedNCT01991899Phase 3
30Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeCompletedNCT01681992Phase 3
31Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 3
32Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136CompletedNCT00751348Phase 3
33Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNCT00192491Phase 3
34Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeCompletedNCT01621802Phase 3
35Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3
36Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3
37Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenCompletedNCT01506193Phase 3
38ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3
39ProQuad® rHA SafetyCompletedNCT00560755Phase 3
40Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3
41Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of AgeCompletedNCT01702428Phase 3
42ProQuad® Intramuscular vs SubcutaneousCompletedNCT00402831Phase 3
43Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered ConcomitantlyCompletedNCT00432042Phase 3
44Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
45Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3
46Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety StudyCompletedNCT00326183Phase 3
47A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3
48Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3
49Comparative Study of Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHACompletedNCT00566527Phase 3
50V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)CompletedNCT00109343Phase 3

Search NIH Clinical Center for Rubella


Cochrane evidence based reviews: rubella

Genetic Tests for Rubella

About this section

Anatomical Context for Rubella

About this section

MalaCards organs/tissues related to Rubella:

36
Skin, Eye, Brain, Heart, Testes, Lymph node, Liver

FMA organs/tissues related to Rubella:

17
Skin

Publications for Rubella

About this section

Articles related to Rubella:

(show top 50)    (show all 1243)
idTitleAuthorsYear
1
FUNDUS AUTOFLUORESCENCE IN RUBELLA RETINOPATHY: Correlation With Photoreceptor Structure and Function. (28005720)
2017
2
Cutaneous and Visceral Chronic Granulomatous Disease Triggered by a Rubella Virus Vaccine Strain in Children With Primary Immunodeficiencies. (27810866)
2017
3
Hospital-based surveillance of congenital rubella syndrome in Indonesia. (28091778)
2017
4
Pancreatic pseudocyst after measles, mumps, and rubella vaccination. (28082255)
2017
5
The end of measles and congenital rubella: an achievable dream? (28067934)
2017
6
Rubella outbreak and outbreak management in a school setting, China, 2014. (27905834)
2016
7
Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010. (27196370)
2016
8
Rubella Immunity in Pregnant Native Taiwanese and Immigrants from Asian Countries. (27895276)
2016
9
An outbreak investigation of congenital rubella syndrome in Solomon Islands, 2013. (27757248)
2016
10
Global measles and rubella laboratory network support for elimination goals, 2010a892015. (27156255)
2016
11
Rubella Immune Status in Pregnant Women in a Northern Mexican City. (27540439)
2016
12
Comparing the rubella seronegativity in pregnant women who received one dose of rubella vaccine at different ages in Taiwan. (27544587)
2016
13
Zika Virus: The New Rubella Epidemic. (27872364)
2016
14
Zika Virus Is More Like Rubella Than Human Immunodeficiency Virus-Reply. (27617894)
2016
15
Genome-Wide Analysis of the Glutathione S-Transferase Gene Family in Capsella rubella: Identification, Expression, and Biochemical Functions. (27630652)
2016
16
Assessing immunity to rubella virus: a plea for standardization of IgG (immuno)assays. (27147722)
2016
17
Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman. (27195163)
2016
18
Is birth cohort 1985/9-1990/8 a susceptibility window for congenital rubella syndrome in Taiwan? (27343317)
2016
19
Localization of Viral Antigens Improves Understanding of Congenital Rubella Syndrome Pathophysiology. (26870811)
2016
20
Spectral Domain-Optical Coherence Tomography Findings in Unilateral Rubella Retinopathy. (27579589)
2016
21
Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. (27613149)
2016
22
Mumps, measles and rubella vaccination in children with PFAPA syndrome. (27997341)
2016
23
Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015. (27148917)
2016
24
Congenital Rubella Syndrome: A Case Report on Changes in Viral Load and Rubella Antibody Titers. (27244797)
2016
25
Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review. (26962867)
2016
26
Considerable decrease of antibody titers against measles, mumps, and rubella in preschool children from an e-waste recycling area. (27591526)
2016
27
Antiviral activity of hemolymph of Podalia against rubella virus. (27896559)
2016
28
Epidemiology of primary rubella infection in the Central African Republic: data from measles surveillance, 2007-2014. (27659859)
2016
29
A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process. (27149048)
2016
30
Genotypes of rubella virus and the epidemiology of rubella infections in the Democratic Republic of the Congo, 2004-2013. (27479298)
2016
31
Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program. (27482805)
2016
32
Maternal Zika infection: like rubella but worse. (27119589)
2016
33
Congenital Rubella. (27732820)
2016
34
Measles and Rubella Seroprevalence Among HIV-Infected And Uninfected Zambian Youth. (27879554)
2016
35
Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University. (27424140)
2016
36
Fetal malformation in maternal toxoplasma and rubella co-infection in Cameroon: a case report. (27912790)
2016
37
Measles-Mumps-Rubella vaccine for children with egg allergy: Is admission for inpatient vaccination necessary? (27770112)
2016
38
Economic impact of switching rubella IgG methodologies to the prenatal public health program in Alberta. (27567094)
2016
39
Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome. (27899091)
2016
40
Congenital rubella syndrome with death from interstitial pneumonia. (26840886)
2016
41
A case of congenital rubella syndrome and infection in South-East London in 2015: prevention, diagnosis, and the public health response. (27884915)
2016
42
Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh. (27519586)
2016
43
Genetic Diversity of Currently Circulating Rubella Viruses: A Need to Define More Precise Viral Groups. (27959771)
2016
44
Inhibitory Activities of Phenolic Compounds Isolated from Adina rubella Leaves Against 5I+-Reductase Associated with Benign Prostatic Hypertrophy. (27399661)
2016
45
Laboratory confirmation of rubella infection in suspected measles cases. (27018071)
2016
46
Zika Virus Is More Like Rubella Than Human Immunodeficiency Virus. (27617787)
2016
47
High levels of susceptibility to measles, mumps and rubella (MMR) in HIV-infected individuals in Ireland. (27118245)
2016
48
Persistence and Half-lives of Anti-measles and Anti-rubella Antibodies in Japanese Hospital Workers: A Longitudinal Study. (27629951)
2016
49
Serological evidence of acute rubella infection among under-fives in Mwanza: a threat to increasing rates of congenital rubella syndrome in Tanzania. (27225802)
2016
50
Vaccine-Preventable Diseases In Pediatric Patients: A Review Of Measles, Mumps, Rubella, And Varicella. (27893360)
2016

Variations for Rubella

About this section

Expression for genes affiliated with Rubella

About this section
Search GEO for disease gene expression data for Rubella.

Pathways for genes affiliated with Rubella

About this section

Pathways related to Rubella according to GeneCards Suite gene sharing:

(show all 26)
idSuper pathwaysScoreTop Affiliating Genes
19.3CALR, HLA-A, HLA-B
29.1HLA-DPB1, HLA-DQB1, HLA-DRB1
39.1HLA-DPB1, HLA-DQB1, HLA-DRB1
4
Show member pathways
9.1HLA-DPB1, HLA-DQB1, HLA-DRB1
5
Show member pathways
9.0HLA-A, HLA-DRB1, IL4
68.9CD40LG, IL4, TNF
7
Show member pathways
8.9CD40LG, IL4, TNF
8
Show member pathways
8.9HLA-A, IFNAR2, TNF
98.7HLA-DRB1, IL4, TNF
108.7HLA-DRB1, IL4, TNF
118.6C1QBP, CD40LG, IL4, TNF
128.2HLA-DPB1, HLA-DQB1, HLA-DRB1, TNF
13
Show member pathways
8.0HLA-A, HLA-B, IFNAR2, IL4, TNF
14
Show member pathways
8.0HLA-A, HLA-B, IFNAR2, IL4, TNF
15
Show member pathways
7.9CD40LG, HLA-A, HLA-DPB1, HLA-DQB1, TNF
167.9CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
177.9CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
187.8HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB, TNF
197.7HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB
20
Show member pathways
7.3HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNAR2
217.1CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
22
Show member pathways
7.1CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB, IL4
23
Show member pathways
6.8CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNAR2, IL10RB
24
Show member pathways
6.3CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1
25
Show member pathways
6.3C1QBP, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
26
Show member pathways
5.5CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1

GO Terms for genes affiliated with Rubella

About this section

Cellular components related to Rubella according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1MHC class I protein complexGO:004261210.4HLA-A, HLA-B
2clathrin-coated endocytic vesicle membraneGO:00306699.8HLA-DPB1, HLA-DQB1, HLA-DRB1
3endocytic vesicle membraneGO:00306669.8HLA-DPB1, HLA-DQB1, HLA-DRB1
4MHC class II protein complexGO:00426139.8HLA-DPB1, HLA-DQB1, HLA-DRB1
5trans-Golgi network membraneGO:00325889.5HLA-DPB1, HLA-DQB1, HLA-DRB1
6external side of plasma membraneGO:00098979.4CALR, CD40LG, IL4, TNF
7transport vesicle membraneGO:00306589.1HLA-DPB1, HLA-DQB1, HLA-DRB1
8ER to Golgi transport vesicle membraneGO:00125079.0HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
9Golgi membraneGO:00001398.9HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
10integral component of lumenal side of endoplasmic reticulum membraneGO:00715568.7CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
11cell surfaceGO:00099867.7C1QBP, CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1
12plasma membraneGO:00058866.4C1QBP, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1

Biological processes related to Rubella according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of dendritic cell chemotaxisGO:200051010.7C1QBP, CALR
2antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independentGO:000248010.3HLA-A, HLA-B
3positive regulation of NIK/NF-kappaB signalingGO:190122410.1CALR, TNF
4regulation of immunoglobulin secretionGO:005102310.1CD40LG, TNF
5positive regulation of T cell proliferationGO:004210210.1CD40LG, HLA-DPB1, IL4
6antigen processing and presentation of peptide antigen via MHC class IGO:000247410.1CALR, HLA-A, HLA-B
7type I interferon signaling pathwayGO:006033710.0HLA-A, HLA-B, IFNAR2
8defense response to virusGO:00516079.9IFNAR2, IL10RB, TRIM22, TRIM5
9positive regulation of chemokine biosynthetic processGO:00450809.8IL4, TNF
10positive regulation of mononuclear cell migrationGO:00716779.8IL4, TNF
11antigen processing and presentation of exogenous peptide antigen via MHC class IIGO:00198869.8HLA-DPB1, HLA-DQB1, HLA-DRB1
12response to virusGO:00096159.7IFNAR2, TNF, TRIM22
13positive regulation of NF-kappaB transcription factor activityGO:00510929.5CD40LG, TNF, TRIM22, TRIM5
14regulation of immune responseGO:00507769.5CD40LG, HLA-A, HLA-B, IL4
15T cell costimulationGO:00312959.5CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1
16positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.2IL4, TNF, TRIM22, TRIM5
17immune responseGO:00069559.1C1QBP, HLA-DQB1, IL10RB, IL4, TRIM22
18viral processGO:00160328.7C1QBP, HLA-A, HLA-B, TRIM22, TRIM5
19interferon-gamma-mediated signaling pathwayGO:00603338.2HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, TRIM22

Molecular functions related to Rubella according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1complement component C1q bindingGO:000184910.3C1QBP, CALR
2peptide antigen bindingGO:00426058.2HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1

Sources for Rubella

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet